rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

PAVmed Inc.

PAVM · Nasdaq

Health CareMedical DevicesNot moving yet

PAVM stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 59.9% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
19 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders19-1 on the quarter
New · exited4 · 5
Reported value$5.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Two Seas Capital LPunchanged · filed 12 Aug 2026461,539$2.7M00.0%
FIRST MANHATTAN CO. LLC.added · filed 14 Aug 2026332,911$2.0M+309,106+1298.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202661,604$366K+55,687+941.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202636,678$218K+24,901+211.4%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202625,605$152K+20,176+371.6%
BlackRock, Inc.added · filed 7 Aug 202617,092$102K+14,676+607.5%
MORGAN STANLEYreduced · filed 13 Aug 2026163$968-2−1.2%
BARCLAYS PLCnew · filed 14 Aug 202675$446+75
SBI Securities Co., Ltd.unchanged · filed 23 Jul 202667$39800.0%
UBS Group AGreduced · filed 13 Aug 202657$339-18−24.0%
31 Dec 2023 – 30 Jun 2026
192530Dec 23Sep 24Mar 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Debra White Company insiderDirector · last 2 Apr 20260 · 0
Dennis M. McGrath Company insiderPresident and CFO · last 2 Apr 20265 · 0
Lishan Aklog Company insiderChairman and CEO · last 2 Apr 202614 · 0
Michael Adam Gordon Company insiderGeneral Counsel · last 2 Apr 20260 · 0
Michael J. Glennon Company insiderDirector · last 2 Apr 20263 · 0
Ronald M. Sparks Company insiderDirector · last 2 Apr 20260 · 0
Shaun O'Neil Company insiderChief Operating Officer · last 2 Apr 20260 · 0
Sundeep Agrawal Company insiderDirector · last 2 Apr 20260 · 0
Timothy E. Baxter Company insiderDirector · last 2 Apr 20260 · 0
Victoria Tou-ho Lee Company insiderChief Medical Officer · last 2 Apr 20260 · 0
James L. Cox Company insiderDirector · last 22 Feb 20240 · 0
Joan B. Harvey Company insiderDirector · last 22 Feb 20240 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-91.0%
Revenue growthFY 2025 · to 31 Dec 2025-97.6%
Share count trendFY 2025 · to 27 Mar 2026588%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.5M
Free cash flowFY 2025 · to 31 Dec 2025−$5.2M

Analyst forecasts

No analyst forecasts yet.